CAPTRUST FINANCIAL ADVISORS - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$0
-100.0%
1000.0%0.00%
Q2 2021$1,0001000.0%0.00%
Q1 2021$01000.0%0.00%
Q4 2020$01000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$0
-100.0%
1000.0%0.00%
Q3 2019$1,0000.0%1000.0%0.00%
Q2 2019$1,0000.0%1000.0%0.00%
Q1 2019$1,0001000.0%0.00%
Q4 2018$0
-100.0%
1000.0%0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,0000.0%1000.0%0.00%
Q1 2018$1,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders